Skip to main content

Table 1 Baseline clinical and laboratory characteristics of the study patients stratified by the primary endpoint

From: Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome

VariableNo such events
n = 588
Primary endpoint
n = 188
P value
Demographics
 Age (years)61 ± 1062 ± 100.498
 Male sex, n (%)426 (72.4)134 (71.3)0.755
 BMI (kg/m2)26.2 ± 3.525.9 ± 3.10.298
Medical measurements (on admission)   
 SBP (mm Hg)132 ± 18131 ± 150.339
 DBP (mm Hg)76 ± 1173 ± 100.001
Risk factors
 Cigarette smoking   
  Current smokers, n (%)238 (40.5)72 (38.3)0.596
  Former smokers, n (%)89 (15.1)35 (18.6)0.257
  Never smokers, n (%)261 (44.4)81 (43.1)0.754
 Alcohol intake
  Daily drinkers, n (%)56 (9.5)18 (9.6)0.984
 Family history of CHD, n (%)172 (29.3)66 (35.1)0.130
 Hypertension, n (%)403 (68.5)129 (68.6)0.984
 Dyslipidaemia, n (%)483 (82.1)163 (86.7)0.145
 Previous MI, n (%)112 (19.0)54 (28.7)0.005
 Past PCI, n (%)120 (20.4)66 (35.1)< 0.001
 Previous CVA, n (%)37 (6.3)11 (5.9)0.827
 PAD, n (%)62 (10.5)54 (28.7)< 0.001
 CKD, n (%)40 (6.8)20 (10.6)0.087
 Cardiac failure, n (%)34 (5.8)28 (14.9)< 0.001
 LVEF (%)65 (60-68)63 (58-68)0.016
Clinical presentation
 UA, n (%)457 (77.7)153 (81.4)0.287
 NSTEMI, n (%)82 (13.9)18 (9.6)0.119
 STEMI, n (%)49 (8.3)17 (9.0)0.762
Laboratory measurements (fasting state)
 TC (mg/dL)157.6 ± 42.5156.0 ± 37.40.638
 LDL-C (mg/dL)93.8 ± 34.991.6 ± 29.50.445
 HDL-C (mg/dL)39.8 ± 9.137.9 ± 7.90.008
 Triglycerides (mg/dL)128.4 (92.1–176.2)145.2 (97.4–201.9)0.039
 FPG (mg/dL)123.8 (109.9–147.2)138.5 (114.2–169.4)< 0.001
 Glycosylated haemoglobin (%)7.2 (6.6–8.1)7.3 (6.8–8.2)0.140
 TyG index9.02 ± 0.579.21 ± 0.53< 0.001
 TyG index tertiles  < 0.001
  T1, n (%)217 (36.9)40 (21.3)
  T2, n (%)194 (33.0)66 (35.1)
  T3, n (%)177 (30.1)82 (43.6)
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, CHD coronary heart disease, MI myocardial infarction, PCI percutaneous coronary intervention, CVA cerebrovascular accident, PAD peripheral artery disease, CKD chronic kidney disease, UA unstable angina, NSTEMI non ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction, TC total cholesterol, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, FPG fasting plasma glucose, TyG triglyceride glucose